Overview

To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets

Status:
Completed
Trial end date:
1987-12-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioequivalency of Cord's 100 mg Desipramine HCl tablets to Merrell Dow's 100 mg Norpramin tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Desipramine